SEATTLE--(BUSINESS WIRE)--Mario Ehlers, M.D., Ph.D., the Chief Medical Officer of Pacific Biometrics, Inc. (OTCBB:PBME) ("PBI"), will present two abstracts at the International Diabetes Federation (IDF) “World Diabetes Congress Conference”. The conference takes place December 3-7 and will be held at the Cape Town International Convention Centre. Dr. Ehlers will present two abstracts: “Subcutaneous Infusion of GLP-1 for 7 Days Improves Glycemic Control Over a Broad Dose Range in Patients with Type 2 Diabetes” and “Subcutaneous Recombinant Glucagon-like Peptide-1 (rGLP-1) Reduces Food Intake in Obese Subjects”.
